# EDWARDS LIFESCIENCES CORPORATION (EW) FY2024 Annual Balance Sheet

- Company: EDWARDS LIFESCIENCES CORPORATION (EW)
- Period: As of 2024-12-31
- Filing: FY2024 10-K, filed 2025-02-28, accession number 0001099800-25-000005
- Page: https://plicit.ai/financials/ew/fy2024-annual-balance-sheet
- Chart image: https://plicit.ai/charts/ew-fy2024-annual-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2024-12-31. The chart shows assets, liabilities and equity at that date.

- **Assets**: 13,055,300,000 US dollars
- **Current assets**: 6,285,400,000 US dollars
- **Non-current assets**: 6,769,900,000 US dollars
- **Liabilities**: 2,992,400,000 US dollars
- **Current liabilities**: 1,505,200,000 US dollars
- **Non-current liabilities**: 1,487,200,000 US dollars
- **Equity**: 10,062,900,000 US dollars
- **Noncontrolling interest**: 64,500,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Cash and cash equivalents**: 3,045,200,000 US dollars
- **Inventories (Note 6)**: 1,086,700,000 US dollars
- **Short-term investments (Note 8)**: 930,700,000 US dollars
- **Accounts receivable, net of allowances of $11.6 and $8.2, respectively**: 609,100,000 US dollars
- **Other current assets**: 347,600,000 US dollars
- **Prepaid expenses**: 121,000,000 US dollars
- **Other receivables**: 118,300,000 US dollars
- **Current assets of discontinued operations (Note 5)**: 26,800,000 US dollars
- **Goodwill (Note 11)**: 1,776,700,000 US dollars
- **Property, plant, and equipment, net (Note 6)**: 1,686,000,000 US dollars
- **Other intangible assets, net (Note 11)**: 1,176,600,000 US dollars
- **Deferred income taxes**: 992,100,000 US dollars
- **Other assets**: 721,600,000 US dollars
- **Long-term investments (Note 8)**: 307,900,000 US dollars
- **Operating lease right-of-use assets (Note 7)**: 98,200,000 US dollars
- **Non-current assets of discontinued operations (Note 5)**: 10,800,000 US dollars
- **Accrued and other liabilities (Note 6)**: 1,282,400,000 US dollars
- **Accounts payable**: 197,400,000 US dollars
- **Operating lease liabilities (Note 7)**: 23,400,000 US dollars
- **Current liabilities of discontinued operations (Note 5)**: 2,000,000 US dollars
- **Long-term debt (Note 12)**: 597,700,000 US dollars
- **Uncertain tax positions (Note 19)**: 384,600,000 US dollars
- **Other liabilities**: 357,500,000 US dollars
- **Operating lease liabilities (Note 7)**: 78,900,000 US dollars
- **Litigation settlement accrual (Note 3)**: 52,700,000 US dollars
- **Contingent consideration liabilities (Note 13)**: 14,500,000 US dollars
- **Taxes payable (Note 19)**: 1,300,000 US dollars
- **Non-current liabilities of discontinued operations (Note 5)**: 0 US dollars
- **Retained earnings**: 13,167,000,000 US dollars
- **Additional paid-in capital**: 2,613,400,000 US dollars
- **Common stock, $1.00 par value, 1,050.0 shares authorized, 654.8 and 650.5 shares issued, and 588.6 and 601.1 shares outstanding, respectively**: 654,800,000 US dollars
- **Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding**: 0 US dollars
- **Noncontrolling interest**: 64,500,000 US dollars
- **Treasury stock, at cost, 66.2 and 49.4 shares, respectively**: negative 6,192,300,000 US dollars
- **Accumulated other comprehensive loss (Note 17)**: negative 244,500,000 US dollars
- **Gross equity (calculated)**: 16,499,700,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.